DNA Methylation Predicts Survival and Response to Therapy in Patients With Myelodysplastic Syndromes
Lanlan Shen(Baylor College of Medicine), Jean‐Pierre J. Issa(Coriell Institute For Medical Research), Sherry Pierce(The University of Texas MD Anderson Cancer Center), Yi Guo(The University of Texas MD Anderson Cancer Center), Yasuhiro Oki(Unknown), Xuelin Huang(The University of Texas MD Anderson Cancer Center), Saira Ahmed(The University of Texas MD Anderson Cancer Center), Yutaka Kondo(Nagoya City University), Hagop M. Kantarjian(The University of Texas MD Anderson Cancer Center), Jianqin Shan(The University of Texas MD Anderson Cancer Center), Wei Zhu(The University of Texas MD Anderson Cancer Center), E Estey(The University of Texas MD Anderson Cancer Center), Hussain I. Saba(University of Tampa), E. Lin(The University of Texas MD Anderson Cancer Center), Donald Berry(The University of Texas MD Anderson Cancer Center), Jaroslav Jelı́nek(Coriell Institute For Medical Research)
Cited by 359
Related Papers
Incidence and functional consequences of <i>hMLH1</i> promoter hypermethylation in colorectal carcinoma
|Proceedings of the National Academy of Sciences|1998|1.9k
An improvement of the 2ˆ(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis.
|PubMed|2013|1.6k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k